SHPH — Shuttle Pharmaceuticals Holdings Cashflow Statement
0.000.00%
Last trade - 00:00Annual cashflow statement for Shuttle Pharmaceuticals Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -1.15 | -3.03 | -6.59 | -9.14 | -11.7 |
| Depreciation | |||||
| Non-Cash Items | -0.094 | 0.867 | 0.784 | 1.67 | 1.52 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.939 | -0.555 | 0.221 | 0.139 | 0.425 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -0.3 | -2.71 | -5.58 | -7.33 | -9.48 |
| Capital Expenditures | 0 | — | -0.019 | — | -3.06 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Software Development Costs | |||||
| Other Investing Cash Flow Items | — | 0 | -2.81 | 2.92 | — |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0 | 0 | -2.83 | 2.92 | -3.06 |
| Financing Cash Flow Items | — | — | -0.345 | -0.263 | -0.612 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.688 | 10.6 | 2.57 | 3.76 | 11 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.388 | 7.91 | -5.84 | -0.656 | -1.59 |